PTC Inc. (PTC)

PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?

Though it's far from a new approach, many exchange-traded funds (ETFs) aiming to provide exposure to the much-hyped artificial intelligence (AI) space tend to lean fairly heavily on a small number of ...

PTC Inc. (PTC) possesses solid growth attributes, which could help it handily outperform the market.

PTC Therapeutics PTCT is currently in the final 18th phase of its Adhishthana cycle on the weekly chart, and the outlook remains bleak. Signals point to prolonged underperformance, with weakness likel...

Company is positioned for growth with SEPHIENCE, approved for PKU in the US and Europe, and pending decisions in Japan and Brazil. Votoplam (PTC518) for Huntington's Disease shows promising phase 2 re...

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like GE, PTC, CRS, PRLB and DDD offer strong growth potential.

Here, we have picked three AI stocks, PTC, AVGO and MSFT, which are well-poised to benefit from AI's growing use and ability to solve complex problems.

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) on Tuesday related to PTC Therapeutics, Inc.‘s PTCT New Drug Application (NDA) for vatiquinone for Friedreich's atax...

The U.S. Food and Drug Administration has declined to approve PTC Therapeutics' drug to treat a rare genetic disorder that causes progressive damage to the nervous system, the company said on Tuesday,...

ZWS, SHG and PTC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2025.